These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein. Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083 [TBL] [Abstract][Full Text] [Related]
7. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease. Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457 [TBL] [Abstract][Full Text] [Related]
8. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Schaeffer E; Kluge A; Böttner M; Zunke F; Cossais F; Berg D; Arnold P Front Cell Dev Biol; 2020; 8():573696. PubMed ID: 33015066 [TBL] [Abstract][Full Text] [Related]
9. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders. Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251 [TBL] [Abstract][Full Text] [Related]
10. In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease. da Silva ANR; Pereira GRC; Bonet LFS; Outeiro TF; De Mesquita JF J Cell Biochem; 2024 Mar; 125(3):e30523. PubMed ID: 38239037 [TBL] [Abstract][Full Text] [Related]
11. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease. Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782 [TBL] [Abstract][Full Text] [Related]
12. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain. Svarcbahs R; Julku UH; Myöhänen TT J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963 [TBL] [Abstract][Full Text] [Related]
14. α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies. Kannarkat GT; Zack R; Skrinak RT; Morley JF; Davila-Rivera R; Arezoumandan S; Dorfmann K; Luk K; Wolk DA; Weintraub D; Tropea TF; Lee EB; Xie SX; Chandrasekaran G; Lee VM; Irwin D; Akhtar RS; Chen-Plotkin AS bioRxiv; 2024 May; ():. PubMed ID: 38765963 [TBL] [Abstract][Full Text] [Related]
15. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies. Magalhães P; Lashuel HA NPJ Parkinsons Dis; 2022 Jul; 8(1):93. PubMed ID: 35869066 [TBL] [Abstract][Full Text] [Related]
16. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein. Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140 [TBL] [Abstract][Full Text] [Related]
17. A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease. Wang Z; Gilliland T; Kim HJ; Gerasimenko M; Sajewski K; Camacho MV; Bebek G; Chen SG; Gunzler SA; Kong Q medRxiv; 2024 Jun; ():. PubMed ID: 38978648 [TBL] [Abstract][Full Text] [Related]
18. Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands. Adler CH; Serrano GE; Shill HA; Driver-Dunckley E; Mehta SH; Zhang N; Glass M; Sue LI; Intorcia A; Beach TG Neurosci Lett; 2024 Mar; 825():137702. PubMed ID: 38395191 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection. Carmo-Gonçalves P; Coelho-Cerqueira E; de Araujo Lima V; Follmer C Expert Rev Neurother; 2023 Apr; 23(4):321-330. PubMed ID: 37016954 [TBL] [Abstract][Full Text] [Related]
20. Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease. Lobanova E; Whiten D; Ruggeri FS; Taylor CG; Kouli A; Xia Z; Emin D; Zhang YP; Lam JYL; Williams-Gray CH; Klenerman D Brain; 2022 Apr; 145(2):632-643. PubMed ID: 34410317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]